Saturday, April 19, 2025
28.8 C
Bengaluru

Dr. Tarun Gupta Tribute Issue

[wpfilebase tag=file id=97 tpl=download-button /]

Inside this Issue – Tributes to Prof. Tarun Gupta

1. Salil Kallianpur

“Like those who create legacies, TG – as he was fondly called – was a man you either loved or hated, but never ignored.”

2. Subroto Banerjee

“People who started their careers in the days when he was still in executive roles, know how big a star he was. I always in awe of Dr. Tarun Gupta.” 

3. Vivek Hattangadi

“He discussed the strategy execution quadrant with me and it is etched into my memory. He concluded describing the quadrant with the message: “Even if your strategy is sound and the execution is sound, the chances of success are just good.”

Hot this week

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends

The pharmaceutical market in 2024 saw major shifts driven...

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Topics

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends

The pharmaceutical market in 2024 saw major shifts driven...

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...
spot_img

Related Articles

spot_imgspot_img